Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 12, 2009, Pages 5275-5278

  Locke, Jeffrey B ^a   Hilgers, Mark ^a   Shaw, Karen Joy ^a  

^a Trius Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; OXAZOLIDINONE DERIVATIVE; PEPTIDYLTRANSFERASE; RIBOSOME PROTEIN; RIBOSOME PROTEIN L3; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; DRUG BINDING SITE; GENE MUTATION; GENE SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ACETAMIDES; BINDING SITES; DRUG RESISTANCE, BACTERIAL; MUTATION; OXAZOLIDINONES; PROTEIN STRUCTURE, SECONDARY; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; TETRAZOLES;

EID: 71249101537     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01032-09     Document Type: Article

References (32)

1. Böck, A., F. Turnowsky, and G. Högenauer. 1982. Tiamulin resistance mutations in Escherichia coli. J. Bacteriol. 151:1253-1260.
2. Bøsling, J., S. M. Poulsen, B. Vester, and K. S. Long. 2003. Resistance to the peptidyl transferase inhibitor tiamulin caused by mutation of ribosomal protein L3. Antimicrob. Agents Chemother. 47:2892-2896.
3. Carsenti-Dellamonica, H., M. Galimand, F. Vandenbos, C. Pradier, P. M. Roger, B. Dunais, M. Sabah, G. Mancini, and P. Dellamonica. 2005. In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. J. Antimicrob. Chemother. 56:633-642.
4. CLSI. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. CLSI document M7-A7, 7th ed., vol.26, no.2. CLSI, Wayne, PA.
5. Davidovich, C., A. Bashan, and A. Yonath. 2008. Structural basis for cross-resistance to ribosomal PTC antibiotics. Proc. Natl. Acad. Sci. USA 105: 20665-20670.
6. DeLano, W. L. 2002. The PyMOL molecular graphics system. DeLano Scientific, Palo Alto, CA.
7. Feng, J., A. Lupien, H. Gingras, J. Wasserscheid, K. Dewar, D. Legare, and M. Ouellette. 2009. Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res. 19:1214-1223.
8. Gentry, D. R., S. F. Rittenhouse, L. McCloskey, and D. J. Holmes. 2007. Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrob. Agents Chemother. 51:2048-2052.
9. Hillemann, D., S. Rüsch-Gerdes, and E. Richter. 2008. In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants. Antimicrob. Agents Chemother. 52:800-801.
10. Jones, R. N., T. R. Fritsche, H. S. Sader, and J. E. Ross. 2007. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diagn. Microbiol. Infect. Dis. 59:309-317.
11. Jones, R. N., G. J. Moet, H. S. Sader, R. E. Mendes, and M. Castanheira. 2009. TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens. J. Antimicrob. Chemother. 63:716-720.
12. Kehrenberg, C., S. Schwarz, L. Jacobsen, L. H. Hansen, and B. Vester. 2005. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol. Microbiol. 57: 1064-1073.
13. Kosowska-Shick K. Clark C. Credito K. McGhee P. Dewasse B. Bogdanovich T. Appelbaum P.C. Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes Antimicrobial Agents and Chemotherapy 2006 50 2 765-769 DOI 10.1128/AAC.50.2.765-769.2006 13. Kosowska-Shick, K., C. Clark, K. Credito, P. McGhee, B. Dewasse, T. Bogdanovich, and P. C. Appelbaum. 2006. Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes. Antimicrob. Agents Chemother. 50:765-769. (Pubitemid 43190997)
14. Livermore, D. M., S. Mushtaq, M. Warner, and N. Woodford. 2009. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci. J. Antimicrob. Chemother. 63:713-715.
15. Lobritz M. Hutton-Thomas R. Marshall S. Rice L.B. Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis Antimicrobial Agents and Chemotherapy 2003 47 10 3318-3320 DOI 10.1128/AAC.47.10.3318-3320.2003 15. Lobritz, M., R. Hutton-Thomas, S. Marshall, and L. B. Rice. 2003. Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis. Antimicrob. Agents Chemother. 47: 3318-3320. (Pubitemid 37229595)
16. Locke, J. B., M. Hilgers, and K. J. Shaw. 2009. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C1-1349.
17. Locke, J. B., M. Hilgers, and K. J. Shaw. 2009. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob. Agents Chemother.
18. Meka, V. G., S. K. Pillai, G. Sakoulas, C. Wennersten, L. Venkataraman, P. C. DeGirolami, G. M. Eliopoulos, R. C. Moellering, and H. S. Gold. 2004. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23s rRNA gene and loss of a single copy of rRNA. J. Infect. Dis. 190:311-317.
19. Mendes, R. E., L. M. Deshpande, M. Castanheira, J. E. Ross, and R. N. Jones. 2009. Abstr. 49th Intersci. Conf. Antimicrobial Agents Chemother., abstr. C2-135.
20. Miller, K., C. J. Dunsmore, C. W. Fishwick, and I. Chopra. 2008. Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center. Antimicrob. Agents Chemother. 52:1737-1742.
21. Pillai, S. K., G. Sakoulas, C. Wennersten, G. M. Eliopoulos, R. C. Moellering, Jr., M. J. Ferraro, and H. S. Gold. 2002. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J. Infect. Dis. 186:1603-1607.
22. Pringle M. Poehlsgaard J. Vester B. Long K.S. Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates Molecular Microbiology 2004 54 5 1295-1306 DOI 10.1111/j.1365-2958.2004.04373.x 22. Pringle, M., J. Poehlsgaard, B. Vester, and K. S. Long. 2004. Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Mol. Microbiol. 54:1295-1306. (Pubitemid 39578272)
23. Prunier, A. L., B. Malbruny, D. Tande, B. Picard, and R. Leclercq. 2002. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob. Agents Chemother. 46:3054-3056.
24. Prystowsky, J., F. Siddiqui, J. Chosay, D. L. Shinabarger, J. Millichap, L. R. Peterson, and G. A. Noskin. 2001. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycinresistant enterococci. Antimicrob. Agents Chemother. 45:2154-2156.
25. Sander, P., L. Belova, Y. G. Kidan, P. Pfister, A. S. Mankin, and E. C. Bottger. 2002. Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations. Mol. Microbiol. 46: 1295-1304.
26. Schaadt, R., D. Sweeney, D. Shinabarger, and G. Zurenko. 2009. In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent. Antimicrob. Agents Chemother. 53:3236-3239.
27. Shaw, K. J., S. Poppe, R. Schaadt, V. Brown-Driver, J. Finn, C. M. Pillar, D. Shinabarger, and G. Zurenko. 2008. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains. Antimicrob. Agents Chemother. 52:4442-4447.
28. Swaney, S. M., D. L. Shinabarger, R. D. Schaadt, J. H. Bock, J. L. Slightom, and G. E. Zurenko. 1998. Abstr. 38th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C-104.
29. Toh, S. M., L. Xiong, C. A. Arias, M. V. Villegas, K. Lolans, J. Quinn, and A. S. Mankin. 2007. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol. Microbiol. 64:1506-1514.
30. Tsiodras, S., H. S. Gold, G. Sakoulas, G. M. Eliopoulos, C. Wennersten, L. Venkataraman, R. C. Moellering, and M. J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207-208.
31. Wilson, D. N., F. Schluenzen, J. M. Harms, A. L. Starosta, S. R. Connell, and P. Fucini. 2008. The oxazolidinone antibiotics perturb the ribosomal peptidyl- transferase center and effect tRNA positioning. Proc. Natl. Acad. Sci. USA 105:13339-13344.
32. Wolter, N., A. M. Smith, D. J. Farrell, W. Schaffner, M. Moore, C. G. Whitney, J. H. Jorgensen, and K. P. Klugman. 2005. Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob. Agents Chemother. 49:3554-3557.